APA (7th ed.) Citation

SW, H., JS, S., JH, M., SA, J., DI, K., Y, R., . . . TW, K. (2020). Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells. Investigational new drugs, 38(6), 1696. https://doi.org/10.1007/s10637-020-00956-9

Chicago Style (17th ed.) Citation

SW, Hong, et al. "Chemosensitivity to HM90822, a Novel Synthetic IAP Antagonist, Is Determined by P-AKT-inducible XIAP Phosphorylation in Human Pancreatic Cancer Cells." Investigational New Drugs 38, no. 6 (2020): 1696. https://doi.org/10.1007/s10637-020-00956-9.

MLA (9th ed.) Citation

SW, Hong, et al. "Chemosensitivity to HM90822, a Novel Synthetic IAP Antagonist, Is Determined by P-AKT-inducible XIAP Phosphorylation in Human Pancreatic Cancer Cells." Investigational New Drugs, vol. 38, no. 6, 2020, p. 1696, https://doi.org/10.1007/s10637-020-00956-9.